PHS
CERE

Pekin Hardy Strauss’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Pekin Hardy Strauss’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,750
Closed -$276K – 366
2024
Q2 		$276K Hold
6,750
– – 0.04% 270
2024
Q1 		$285K Buy
+6,750
New +$285K 0.04% 276